Entry |
|
Name |
Eribaxaban (USAN) |
Formula |
C24H22ClFN4O4
|
Exact mass |
484.1314
|
Mol weight |
484.9073
|
Structure |
|
Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01662 Factor Xa inhibitor
|
Efficacy |
Antithrombotic, Factor Xa inhibitor |
Comment |
Treatment of thromboembolic disorders
|
Target |
|
Pathway |
hsa04610 | Complement and coagulation cascades |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01662 Factor Xa inhibitor
D08913 Eribaxaban
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Serine peptidases
F10
D08913 Eribaxaban (USAN)
|
Other DBs |
|
KCF data |
ATOM 34
1 C8x C 17.3718 -14.7105
2 C8y C 17.3718 -16.1114
3 C8x C 18.5850 -16.8119
4 C8y C 19.7984 -16.1114
5 C8y C 19.7984 -14.7105
6 C8x C 18.5850 -14.0100
7 N1b N 21.0303 -13.9990
8 C5a C 22.2363 -14.6952
9 C1y C 23.4194 -14.0119
10 N1y N 24.6788 -14.5726
11 C1x C 25.6013 -13.5480
12 C1y C 24.9120 -12.3541
13 C1x C 23.5635 -12.6408
14 C5a C 24.6788 -15.9735
15 N1b N 25.8920 -16.6740
16 C8y C 27.1253 -15.9618
17 C8x C 28.3299 -16.6572
18 C8x C 29.5431 -15.9567
19 C8y C 29.5431 -14.5558
20 C8x C 28.3384 -13.8603
21 C8x C 27.1252 -14.5609
22 X Cl 30.7625 -13.8515
23 O5a O 23.4501 -16.6831
24 O5a O 22.2368 -16.1110
25 X F 21.0303 -16.8229
26 N4y N 16.1586 -16.8119
27 C8x C 14.9623 -16.1210
28 C8x C 13.7490 -16.8213
29 C8x C 13.7488 -18.2222
30 C8x C 14.9451 -18.9131
31 C8y C 16.1584 -18.2128
32 O5x O 17.3884 -18.9233
33 O2a O 25.4955 -11.0438
34 C1a C 26.8708 -10.8995
BOND 37
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 9 8 1 #Up
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 9 13 1
15 10 14 1
16 14 15 1
17 15 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 19 20 1
22 20 21 2
23 16 21 1
24 19 22 1
25 14 23 2
26 8 24 2
27 4 25 1
28 2 26 1
29 26 27 1
30 27 28 2
31 28 29 1
32 29 30 2
33 30 31 1
34 26 31 1
35 31 32 2
36 12 33 1 #Up
37 33 34 1
|